Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 24655355)

1.

Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.

Li J, Luo J, Luo YQ, Zhou M, Zhao L, Yao LJ, Dong H, Yang RN.

Transfusion. 2014 Aug;54(8):2106-17. doi: 10.1111/trf.12617. Epub 2014 Mar 24.

PMID:
24655355
2.

Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.

Figueiredo C, Blaszczyk R.

J Stem Cells. 2014;9(3):149-61. doi: jsc.2014.9.3.149. Review.

PMID:
25157449
3.

Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets.

Wang J, Chen S, Zhang C, Stegeman S, Pfaff-Amesse T, Zhang Y, Zhang W, Amesse L, Chen Y.

PLoS One. 2012;7(8):e44300. doi: 10.1371/journal.pone.0044300. Epub 2012 Aug 31.

4.

HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model.

Gras C, Schulze K, Goudeva L, Guzman CA, Blasczyk R, Figueiredo C.

Hum Gene Ther. 2013 Dec;24(12):1018-28. doi: 10.1089/hum.2013.074. Epub 2013 Nov 7.

PMID:
24090417
5.

OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.

Matsubara Y, Ono Y, Suzuki H, Arai F, Suda T, Murata M, Ikeda Y.

PLoS One. 2013;8(3):e58123. doi: 10.1371/journal.pone.0058123. Epub 2013 Mar 1.

6.

Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.

Cramer EM, Norol F, Guichard J, Breton-Gorius J, Vainchenker W, Massé JM, Debili N.

Blood. 1997 Apr 1;89(7):2336-46.

7.

Expression of a foreign protein in human megakaryocytes and platelets by retrovirally mediated gene transfer.

Burstein SA, Dubart A, Norol F, Debili N, Friese P, Downs T, Yu X, Kincade PW, Villeval JL, Vainchenker W.

Exp Hematol. 1999 Jan;27(1):110-6.

PMID:
9923449
8.

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.

Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4766-71. Epub 2003 Apr 7.

9.

Generation of functional platelets from canine induced pluripotent stem cells.

Nishimura T, Hatoya S, Kanegi R, Sugiura K, Wijewardana V, Kuwamura M, Tanaka M, Yamate J, Izawa T, Takahashi M, Kawate N, Tamada H, Imai H, Inaba T.

Stem Cells Dev. 2013 Jul 15;22(14):2026-35. doi: 10.1089/scd.2012.0701. Epub 2013 Mar 15.

PMID:
23409943
10.

Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.

Burgess JK, Boustany S, Moir LM, Weckmann M, Lau JY, Grafton K, Baraket M, Hansbro PM, Hansbro NG, Foster PS, Black JL, Oliver BG.

Am J Respir Crit Care Med. 2010 Jan 15;181(2):106-15. doi: 10.1164/rccm.200904-0631OC. Epub 2009 Oct 29.

PMID:
19875687
11.

Effects of cytokines on platelet production from blood and marrow CD34+ cells.

Norol F, Vitrat N, Cramer E, Guichard J, Burstein SA, Vainchenker W, Debili N.

Blood. 1998 Feb 1;91(3):830-43.

12.

[The cloning and expression of angiogenic inhibitor tumstatin(45-132) in E. coli].

Luo YQ, Wang LH, Qiu Y, Jiao BH.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Mar;21(2):141-3. Chinese.

PMID:
15766393
13.

Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli.

Luo YQ, Wang LH, Yi Q, Jiao BH.

Clin Exp Med. 2008 Mar;8(1):37-42. doi: 10.1007/s10238-008-0154-2. Epub 2008 Apr 3.

PMID:
18385939
14.

Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis.

Meyer SC, Keller MD, Woods BA, LaFave LM, Bastian L, Kleppe M, Bhagwat N, Marubayashi S, Levine RL.

Blood. 2014 Oct 2;124(14):2280-4. doi: 10.1182/blood-2014-03-560441. Epub 2014 Aug 12.

PMID:
25115888
15.

Silencing of a targeted protein in in vivo platelets using a lentiviral vector delivering short hairpin RNA sequence.

Ohmori T, Kashiwakura Y, Ishiwata A, Madoiwa S, Mimuro J, Sakata Y.

Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2266-72. Epub 2007 Sep 13.

16.

Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.

Yao B, He QM, Tian L, Xiao F, Jiang Y, Zhang R, Li G, Zhang L, Hou JM, Wang L, Cheng XC, Wen YJ, Kan B, Li J, Zhao X, Hu B, Zhou Q, Zhang L, Wei YQ.

Hum Gene Ther. 2005 Sep;16(9):1075-86.

PMID:
16149906
17.

Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.

Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.

Chin Med J (Engl). 2008 Nov 20;121(22):2324-30.

PMID:
19080341
18.

Effect of increased HoxB4 on human megakaryocytic development.

Zhong Y, Sullenbarger B, Lasky LC.

Biochem Biophys Res Commun. 2010 Jul 30;398(3):377-82. doi: 10.1016/j.bbrc.2010.06.075. Epub 2010 Jun 22.

19.

Bone marrow stromal cells transduced with a thrombopoietin, interleukin-6, and interleukin-11 syncretic gene induce cord mononuclear cells to generate platelets in vitro.

Lu H, Jiang T, Li R, Wang S, Zhang Q, Zhao S.

Transfusion. 2015 Jan;55(1):176-86. doi: 10.1111/trf.12800. Epub 2014 Sep 23.

PMID:
25251668
20.

Tumstatin transfected into human glioma cell line U251 represses tumor growth by inhibiting angiogenesis.

Ye HX, Yao Y, Jiang XJ, Yuan XR.

Chin Med J (Engl). 2013;126(9):1720-5.

PMID:
23652057
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk